Peryton: a manual collection of experimentally supported microbe-disease associations

Abstract We present Peryton (https://dianalab.e-ce.uth.gr/peryton/), a database of experimentally supported microbe-disease associations. Its first version constitutes a novel resource hosting more than 7900 entries linking 43 diseases with 1396 microorganisms. Peryton's content is exclusively sustained by manual curation of biomedical articles. Diseases and microorganisms are provided in a systematic, standardized manner using reference resources to create database dictionaries. Information about the experimental design, study cohorts and the applied high- or low-throughput techniques is meticulously annotated and catered to users. Several functionalities are provided to enhance user experience and enable ingenious use of Peryton. One or more microorganisms and/or diseases can be queried at the same time. Advanced filtering options and direct text-based filtering of results enable refinement of returned information and the conducting of tailored queries suitable to different research questions. Peryton also provides interactive visualizations to effectively capture different aspects of its content and results can be directly downloaded for local storage and downstream analyses. Peryton will serve as a valuable source, enabling scientists of microbe-related disease fields to form novel hypotheses but, equally importantly, to assist in cross-validation of findings.

[1]  J. Nielandt,et al.  Disbiome database: linking the microbiome to disease , 2018, BMC Microbiology.

[2]  D. Kobayashi,et al.  Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer , 2013, Digestive Diseases and Sciences.

[3]  Hongyi Yang,et al.  Factors affecting the composition of the gut microbiota, and its modulation , 2019, PeerJ.

[4]  Robert D. Finn,et al.  A unified catalog of 204,938 reference genomes from the human gut microbiome , 2020, Nature Biotechnology.

[5]  V. Young,et al.  The gut microbiome in health and in disease , 2015, Current opinion in gastroenterology.

[6]  Katherine H. Huang,et al.  Identifying personal microbiomes using metagenomic codes , 2015, Proceedings of the National Academy of Sciences.

[7]  S. Lynch,et al.  The gut microbiome: Relationships with disease and opportunities for therapy , 2018, The Journal of experimental medicine.

[8]  Scott Federhen,et al.  The NCBI Taxonomy database , 2011, Nucleic Acids Res..

[9]  Rob Knight,et al.  Current understanding of the human microbiome , 2018, Nature Medicine.

[10]  Jennifer M. Fettweis,et al.  The Integrative Human Microbiome Project , 2019, Nature.

[11]  NIH Human Microbiome Portfolio Analysis Team,et al.  A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016 , 2019 .

[12]  T. Ohkusa,et al.  Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species‐specific antibody , 2002, Journal of gastroenterology and hepatology.

[13]  Liang Cheng,et al.  gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions , 2019, Nucleic acids research.

[14]  Donna Neuberg,et al.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.

[15]  A. Clark.  The Human Microbiome. , 2017, The American journal of nursing.

[16]  Rob Knight,et al.  Challenges in the construction of knowledge bases for human microbiome-disease associations , 2019, Microbiome.

[17]  R. Schlaberg.  Microbiome Diagnostics. , 2019, Clinical chemistry.

[18]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[19]  C. Jobin,et al.  Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin , 2018, Gut.

[20]  Rob Knight,et al.  Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations. , 2019, Trends in microbiology.

[21]  Rob Knight,et al.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.

[22]  D. Sahoo,et al.  Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1 , 2019, EMBO reports.

[23]  the International Network Medicine Consortium.  The Integrative Human Microbiome Project , 2019 .

[24]  M. Levy,et al.  New Approaches to Microbiome-Based Therapies , 2019, mSystems.

[25]  L. Lerman,et al.  Coronary artery disease is associated with an altered gut microbiome composition , 2020, PloS one.

[26]  D. Huson,et al.  SILVA, RDP, Greengenes, NCBI and OTT — how do these taxonomies compare? , 2017, BMC Genomics.

[27]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[28]  Subha Madhavan,et al.  iTextMine: integrated text-mining system for large-scale knowledge extraction from the literature , 2018, Database J. Biol. Databases Curation.

[29]  Fangfang Guo,et al.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.

[30]  J. Bard,et al.  Intestinal Proportion of Blautia sp. is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer , 2017, Nutrition and cancer.

[31]  Christophe Caron,et al.  Towards the human intestinal microbiota phylogenetic core. , 2009, Environmental microbiology.